T1	Participants 220 572	patients treated for localized prostatic carcinoma in a Phase III radiotherapy (RT) protocol, Radiation Therapy Oncology Group (RTOG) 77-06. Patients with T18N0M0 (A2) or T2N0M0 (B) disease after lymphangiogram (LAG) or staging laparotomy (SL) were randomized between prophylactic radiation to the pelvic lymph nodes and prostatic bed vs. prostatic bed
T2	Participants 718 779	A total of 449 eligible males were entered into RTOG protocol
T3	Participants 886 927	patients had SL, while 332 (74%) had LAG.